Skip to search boxSkip to navigationSkip to main content

Movement disorders induced by dopamine blocking agents

  • K. D. Sethi(corresponding author)
*Corresponding author for this work
Scholary Output:
Contribution to journal
Review article
Peer-review

Abstract

Movement disorders are frequently due to dopamine blocking agents (DBAs) prescribed for psychiatric illnesses. DBAs are sometimes also prescribed inappropriately for other maladies. These drugs can cause a wide variety of involuntary movements, sometimes in combination. When these appear in the setting of psychiatric illnesses, the association is easy to recognize but the treatment remains a difficult problem. However, in other situations the diagnosis may be missed for extended periods of time, resulting in unnecessary diagnostic work-up and inappropriate therapy. The diagnosis depends on a compulsive drug history not only from the patient but also from patient's family, primary physician, and the pharmacist. The treatment options include removal of the offending agent or substitution with an atypical neuroleptic. Symptomatic treatments are varied and have an inconsistent effect on the movement disorders. Prevention remains the most important strategy.

Publication Information

Output type

Scholary Output:
Contribution to journal
Review article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 59-68 (10 pages)

Journal (Volume, Issue Number)

Seminars in Neurology (Volume 21, Issue 1)

Publication milestones

  • Published - 01/01/2001

Publication status

Published - 01/01/2001

ISSN

0271-8235

Publication IDs

  • Scopus: 0035028237
  • PubMed: 11346026

Publication metrics

Metrics

Scopus
citations
SciVal
FWCI
0.33
SciVal
Author count
1
SciVal
citations
35
SciVal
Paper percentile
80
Fractional count
1
Fractional count
1
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Captures
39
Citation count
51